Search research articles
Contact Us
Filters
Showing results (51-60 of 107) with videos related to
Page
of 11
Sort By:
Journal of the American Heart Association
|
May 9, 2023
Clinical Profile, Health Care Costs, and Outcomes of Patients Hospitalized for Heart Failure With Severely Reduced Ejection Fraction
Josephine Harrington, Jie-Lena Sun, Gregg C Fonarow, et al.
Heart Rhythm
|
February 22, 2020
Appropriate and inappropriate shocks in hypertrophic cardiomyopathy patients with subcutaneous implantable cardioverter-defibrillators: An international multicenter study
Babak Nazer, Zack Dale, Gianmarco Carrassa, et al.
Heart Rhythm
|
September 2, 2025
Low Incidence of Atrial Fibrillation in Patients with Obstructive HCM Treated with Aficamten: An Analysis from the REDWOOD-HCM, SEQUOIA-HCM and FOREST-HCM Trials
Ethan J Rowin, Martin S Maron, Iacopo Olivotto, et al.
JACC. Heart Failure
|
February 1, 2024
Tricuspid Regurgitation and Clinical Outcomes in Heart Failure With Reduced Ejection Fraction
Marianna Adamo, Marco Metra, Brian L Claggett, et al.
Heart Rhythm
|
December 21, 2021
Importance of newer cardiac magnetic resonance-based risk markers for sudden death prevention in hypertrophic cardiomyopathy: An international multicenter study
Ethan J Rowin, Martin S Maron, Arnon Adler, et al.
Journal of Inherited Metabolic Disease
|
September 6, 2017
Triheptanoin versus trioctanoin for long-chain fatty acid oxidation disorders: a double blinded, randomized controlled trial
Melanie B Gillingham, Stephen B Heitner, Julie Martin, et al.
Circulation. Heart Failure
|
March 3, 2022
Developments in Exercise Capacity Assessment in Heart Failure Clinical Trials and the Rationale for the Design of METEORIC-HF
Gregory D Lewis, Kieran F Docherty, Adriaan A Voors, et al.
European Heart Journal
|
August 31, 2025
Serum magnesium and outcomes in heart failure with reduced ejection fraction: the GALACTIC-HF trial
Misato Chimura, Kieran F Docherty, Pardeep S Jhund, et al.
Journal of the American College of Cardiology
|
March 20, 2019
Transthyretin Stabilization by AG10 in Symptomatic Transthyretin Amyloid Cardiomyopathy
Daniel P Judge, Stephen B Heitner, Rodney H Falk, et al.
JACC. Heart Failure
|
January 13, 2026
Lactate Dehydrogenase and Outcomes in Patients With HF and Reduced Ejection Fraction: Insights From GALACTIC-HF
Ryohei Ono, Misato Chimura, Kieran F Docherty, et al.
Page
of 11
Search research articles
Search
Showing results (51-60 of 107) with videos related to
Sort By:
Page
of 11
Journal of the American Heart Association
|
May 9, 2023
Clinical Profile, Health Care Costs, and Outcomes of Patients Hospitalized for Heart Failure With Severely Reduced Ejection Fraction
Josephine Harrington, Jie-Lena Sun, Gregg C Fonarow, et al.
Heart Rhythm
|
February 22, 2020
Appropriate and inappropriate shocks in hypertrophic cardiomyopathy patients with subcutaneous implantable cardioverter-defibrillators: An international multicenter study
Babak Nazer, Zack Dale, Gianmarco Carrassa, et al.
Heart Rhythm
|
September 2, 2025
Low Incidence of Atrial Fibrillation in Patients with Obstructive HCM Treated with Aficamten: An Analysis from the REDWOOD-HCM, SEQUOIA-HCM and FOREST-HCM Trials
Ethan J Rowin, Martin S Maron, Iacopo Olivotto, et al.
JACC. Heart Failure
|
February 1, 2024
Tricuspid Regurgitation and Clinical Outcomes in Heart Failure With Reduced Ejection Fraction
Marianna Adamo, Marco Metra, Brian L Claggett, et al.
Heart Rhythm
|
December 21, 2021
Importance of newer cardiac magnetic resonance-based risk markers for sudden death prevention in hypertrophic cardiomyopathy: An international multicenter study
Ethan J Rowin, Martin S Maron, Arnon Adler, et al.
Journal of Inherited Metabolic Disease
|
September 6, 2017
Triheptanoin versus trioctanoin for long-chain fatty acid oxidation disorders: a double blinded, randomized controlled trial
Melanie B Gillingham, Stephen B Heitner, Julie Martin, et al.
Circulation. Heart Failure
|
March 3, 2022
Developments in Exercise Capacity Assessment in Heart Failure Clinical Trials and the Rationale for the Design of METEORIC-HF
Gregory D Lewis, Kieran F Docherty, Adriaan A Voors, et al.
European Heart Journal
|
August 31, 2025
Serum magnesium and outcomes in heart failure with reduced ejection fraction: the GALACTIC-HF trial
Misato Chimura, Kieran F Docherty, Pardeep S Jhund, et al.
Journal of the American College of Cardiology
|
March 20, 2019
Transthyretin Stabilization by AG10 in Symptomatic Transthyretin Amyloid Cardiomyopathy
Daniel P Judge, Stephen B Heitner, Rodney H Falk, et al.
JACC. Heart Failure
|
January 13, 2026
Lactate Dehydrogenase and Outcomes in Patients With HF and Reduced Ejection Fraction: Insights From GALACTIC-HF
Ryohei Ono, Misato Chimura, Kieran F Docherty, et al.
Page
of 11